Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Clinical trial NCT00638690 · COMPLETED

Trial details

NCT number: NCT00638690
Sponsor: Cougar Biotechnology, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2008-05-01
Primary completion: 2010-08-01
Enrollment: 1195

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.